OVID logo

Ovid Therapeutics Inc.

OVID
Healthcare|Biotechnology|US
$2.85
+0.27 (+10.47%)
Tangible Book / Share
$2.85
Cash / Share
$1.59

Ownership Breakdown

83.7%
Float
195.3M
Shares Outstanding
163.4M
Float Shares

Major Holders (40)

Combined: 249.3%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Takeda Pharmaceutical Company LimitedCorporation12.30%8,781,996Dec 9, 202513D/G
Janus Henderson Group PLCIA, HC9.99%7,114,114Dec 8, 202513D/G
RA Capital Healthcare Fund, L.P.Partnership9.90%19,549,271Aug 14, 202613D/G
Rajeev ShahHC, IN9.90%19,549,271Aug 14, 202613D/G
Peter KolchinskyHC, IN9.90%19,549,271Aug 14, 202613D/G
RA Capital Management, L.P.IA, PN9.90%19,549,271Aug 14, 202613D/G
Alex SilversteinHC, IN9.90%18,031,333May 15, 202613D/G
Sirenia Capital Management LPIA, PN9.90%18,031,333May 15, 202613D/G
Takeda Pharmaceutical U.S.A., Inc.Corporation9.80%7,000,000Dec 9, 202513D/G
Affinity Healthcare Fund, LPPartnership9.00%12,149,166Dec 18, 202513D/G
Affinity Asset Advisors, LLCIA, OO7.90%15,143,728Aug 13, 202613D/G
Michael ChoHC, IN7.90%15,143,728Aug 13, 202613D/G
Finny Kuruvilla, M.D., Ph. D.HC, IN6.30%11,812,241Aug 14, 202613D/G
Robin C. JohnHC, IN6.30%11,812,241Aug 14, 202613D/G
Eventide Asset Management, LLCInvestment adviser6.30%11,812,241Aug 14, 202613D/G
BlackRock, Inc.Holding company5.80%10,822,672Jul 29, 202613D/G
Mark N. LampertIndividual5.40%3,853,818Nov 14, 202413D/G
BVF Inc.Corporation5.40%3,853,818Nov 14, 202413D/G
BVF Partners L.P.IA, PN5.40%3,853,818Nov 14, 202413D/G
Daniel SchneebergerHC, IN5.10%9,559,979Aug 14, 202613D/G
ADAR1 Capital Management, LLCIA, OO5.10%9,559,979Aug 14, 202613D/G
Bam GP LLCHC, OO4.99%9,313,341Aug 14, 202613D/G
Dames GP LLCHC, OO4.99%9,313,341Aug 14, 202613D/G
Balyasny Asset Management Holdings LPHC, PN4.99%9,313,341Aug 14, 202613D/G
Balyasny Asset Management L.P.IA, PN4.99%9,313,341Aug 14, 202613D/G
Dmitry BalyasnyHC, IN4.99%9,313,341Aug 14, 202613D/G
ADAR1 Capital Management GP, LLCOther4.90%9,122,588Aug 14, 202613D/G
Jeremy M. LevinIndividual4.50%8,551,502May 14, 202613D/G
J. Christopher DonahueIndividual4.15%7,737,166Jul 8, 202613D/G
Ann C. DonahueIndividual4.15%7,737,166Jul 8, 202613D/G
Thomas R. DonahueIndividual4.15%7,737,166Jul 8, 202613D/G
Voting Shares Irrevocable TrustOther4.15%7,737,166Jul 8, 202613D/G
Federated Hermes, Inc.Holding company4.15%7,737,166Jul 8, 202613D/G
Madison Avenue Partners, LPOther4.00%2,852,352Feb 14, 202513D/G
Madison Avenue International LPOther4.00%2,852,352Feb 14, 202513D/G
EMAI Management, LLCOther4.00%2,852,352Feb 14, 202513D/G
Madison Avenue GP, LLCOther4.00%2,852,352Feb 14, 202513D/G
Caraway Jackson Investments LLCOther4.00%2,852,352Feb 14, 202513D/G
Eli SamahaIndividual4.00%2,852,352Feb 14, 202513D/G
Biotechnology Value Fund, L.P.Partnership2.80%1,982,803Nov 14, 202413D/G

Insider Trades (100)

Last 4 quarters: 5,759,057 acquired · 68,851 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Carter Charles RossChief Financial OfficerJul 6, 2026AWARD50,000——Form 4
Carter Charles RossChief Financial OfficerJul 6, 2026OTHER0——Form 4
Carter Charles RossChief Financial OfficerJul 6, 2026OTHER200,000$1.14$228.0KForm 4
Carter Charles RossChief Financial OfficerJul 6, 2026OTHER206,250$1.65$340.3KForm 4
Greka AnnadirectorJun 15, 2026AWARD130,000$2.26$293.8KForm 4
Greka AnnaJun 15, 2026OTHER0——Form 4
PAPADOPOULOS STELIOSdirectorApr 7, 2026AWARD17,578$2.56$45.0KForm 4
Friedman BartdirectorApr 7, 2026AWARD8,789$2.56$22.5KForm 4
Fitzgerald Kevin JosephdirectorApr 7, 2026AWARD17,578$2.56$45.0KForm 4
LEVIN JEREMY Mdirector, officer: Executive ChairmanMar 23, 2026OPTION EX.47,333$1.40$66.3KForm 4
LEVIN JEREMY Mdirector, officer: Executive ChairmanMar 23, 2026OPTION EX.47,333$1.40$66.3KForm 4
ALEXANDER MARGARET A.director, officer: President and CEOFeb 26, 2026AWARD1,435,000$1.65$2.4MForm 4
ALEXANDER MARGARET A.director, officer: President and CEOFeb 23, 2026SELL11,656$1.45$16.9KForm 4
PAPADOPOULOS STELIOSdirectorFeb 26, 2026AWARD65,000$1.65$107.3KForm 4
LEVIN JEREMY MdirectorFeb 26, 2026AWARD957,000$1.65$1.6MForm 4
Fitzgerald Kevin JosephdirectorFeb 26, 2026AWARD65,000$1.65$107.3KForm 4
Friedman BartdirectorFeb 26, 2026AWARD65,000$1.65$107.3KForm 4
DUNCAN BARBARA GAYLEdirectorFeb 26, 2026AWARD65,000$1.65$107.3KForm 4
Bernstein KarendirectorFeb 26, 2026AWARD65,000$1.65$107.3KForm 4
Rona Jeffrey ACBFOFeb 26, 2026AWARD408,750$1.65$674.4KForm 4
Rona Jeffrey ACBFOFeb 26, 2026AWARD68,125——Form 4
Rona Jeffrey ACBFOFeb 23, 2026SELL8,541$1.45$12.4KForm 4
ALEXANDER MARGARET A.director, officer: President and CEOJan 4, 2026AWARD890,000$1.76$1.6MForm 4
LEVIN JEREMY Mdirector, officer: CEODec 15, 2025CONVERSION71,000——Form 4
LEVIN JEREMY Mdirector, officer: CEODec 11, 2025BUY47,333$1.40$66.3KForm 4
LEVIN JEREMY Mdirector, officer: CEODec 11, 2025BUY35,500$1.40$49.7KForm 4
LEVIN JEREMY Mdirector, officer: CEODec 11, 2025BUY71——Form 4
LEVIN JEREMY Mdirector, officer: CEODec 15, 2025CONVERSION71——Form 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerDec 8, 2025CONVERSION1,250,000——Form 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerDec 8, 2025CONVERSION1,250——Form 4
Fitzgerald Kevin JosephdirectorFeb 20, 2025AWARD45,000$0.57$25.6KForm 4
Friedman BartdirectorFeb 20, 2025AWARD45,000$0.57$25.6KForm 4
Duncan Barbara GayledirectorFeb 20, 2025AWARD45,000$0.57$25.6KForm 4
Bernstein KarendirectorFeb 20, 2025AWARD45,000$0.57$25.6KForm 4
PAPADOPOULOS STELIOSdirectorMar 3, 2025AWARD90,000$0.49$44.1KForm 4
PAPADOPOULOS STELIOSdirectorMar 1, 2025OTHER0——Form 4
ALEXANDER MARGARET A.President and COOFeb 26, 2025SELL5,279$0.56$3.0KForm 4
Rona Jeffrey ACBFOFeb 26, 2025SELL3,902$0.56$2.2KForm 4
LEVIN JEREMY Mdirector, officer: CEOFeb 20, 2025AWARD1,650,000$0.57$940.5KForm 4
Rona Jeffrey ACBFOFeb 20, 2025AWARD262,500$0.57$149.6KForm 4
Rona Jeffrey ACBFOFeb 20, 2025AWARD43,750——Form 4
ALEXANDER MARGARET A.President and COOFeb 20, 2025AWARD262,500$0.57$149.6KForm 4
ALEXANDER MARGARET A.President and COOFeb 20, 2025AWARD43,750——Form 4
ALEXANDER MARGARET A.President and COOJan 27, 2025BUY6,810$0.73$5.0KForm 4
Fitzgerald Kevin JosephdirectorDec 12, 2024AWARD90,000$1.06$95.4KForm 4
Friedman BartdirectorDec 12, 2024AWARD90,000$1.06$95.4KForm 4
Duncan Barbara GayledirectorDec 12, 2024AWARD90,000$1.06$95.4KForm 4
Bernstein KarendirectorDec 12, 2024AWARD90,000$1.06$95.4KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024AWARD140,000$1.07$149.8KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED0——Form 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED175,000$2.50$437.5KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED315,000$1.05$330.8KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED100,000$2.72$272.0KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED70,000$3.73$261.1KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED2,021$3.74$7.6KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED10,000$3.22$32.2KForm 4
ALEXANDER MARGARET A.President and COOSep 9, 2024DISPOSED168,750$3.68$621.0KForm 4
Rona Jeffrey ACBFOJul 30, 2024AWARD315,000$1.04$329.2KForm 4
LEVIN JEREMY Mdirector, officer: CEOMar 18, 2024BUY18,248$2.76$50.4KForm 4
Tardio JasonChief Operating OfficerFeb 22, 2024AWARD168,750$3.68$621.0KForm 4
Tardio JasonChief Operating OfficerFeb 22, 2024AWARD28,125——Form 4
Rona Jeffrey ACBFOFeb 22, 2024AWARD28,125——Form 4
Rona Jeffrey ACBFOFeb 22, 2024AWARD168,750$3.68$621.0KForm 4
Poole Robert MichaeldirectorFeb 22, 2024AWARD30,000$3.68$110.4KForm 4
Perone Thomas MichaelGeneral Counsel, SecretaryFeb 22, 2024AWARD168,750$3.68$621.0KForm 4
Perone Thomas MichaelGeneral Counsel, SecretaryFeb 22, 2024AWARD28,125——Form 4
LEVIN JEREMY Mdirector, officer: CEOFeb 22, 2024AWARD700,000$3.68$2.6MForm 4
Friedman BartdirectorFeb 22, 2024AWARD30,000$3.68$110.4KForm 4
Fitzgerald Kevin JosephdirectorFeb 22, 2024AWARD30,000$3.68$110.4KForm 4
Duncan Barbara GayledirectorFeb 22, 2024AWARD30,000$3.68$110.4KForm 4
Bernstein KarendirectorFeb 22, 2024AWARD30,000$3.68$110.4KForm 4
LEVIN JEREMY Mdirector, officer: CEOSep 20, 2019GIFT465,116——Form 4
LEVIN JEREMY Mdirector, officer: CEODec 4, 2023GIFT573,275——Form 4
LEVIN JEREMY Mdirector, officer: CEODec 4, 2023GIFT573,275——Form 4
Tardio JasonChief Operating OfficerFeb 23, 2023AWARD175,000$2.50$437.5KForm 4
Rona Jeffrey ACBFOFeb 23, 2023AWARD175,000$2.50$437.5KForm 4
Poole Robert MichaeldirectorFeb 23, 2023AWARD15,000$2.50$37.5KForm 4
Perone Thomas MichaelGeneral Counsel, SecretaryFeb 23, 2023AWARD175,000$2.50$437.5KForm 4
LEVIN JEREMY Mdirector, 10 percent owner, officer: CEOFeb 23, 2023AWARD600,000$2.50$1.5MForm 4
Friedman BartdirectorFeb 23, 2023AWARD15,000$2.50$37.5KForm 4
Fitzgerald Kevin JosephdirectorFeb 23, 2023AWARD15,000$2.50$37.5KForm 4
Duncan Barbara GayledirectorFeb 23, 2023AWARD15,000$2.50$37.5KForm 4
Bernstein KarendirectorFeb 23, 2023AWARD15,000$2.50$37.5KForm 4
Tardio JasonChief Operating OfficerSep 12, 2022SELL17,344$2.15$37.3KForm 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerJul 1, 2022J5,750,000——Form 4
Takeda Pharmaceuticals U.S.A., Inc.director: Jul 1, 2022J1,250——Form 4
Takeda Pharmaceuticals U.S.A., Inc.director: Jul 1, 2022J1,250——Form 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerJul 1, 2022J1,250——Form 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerJul 1, 2022DISPOSED1,250——Form 4
TAKEDA PHARMACEUTICAL CO LTD10 percent ownerJul 1, 2022DISPOSED5,750,000——Form 4
Friedman Bartdirector: Apr 8, 2022AWARD69,424——Form 4
Tardio JasonChief Operating OfficerApr 8, 2022AWARD87,498$3.22$281.7KForm 4
Tardio JasonChief Operating OfficerApr 8, 2022AWARD10,000$3.22$32.2KForm 4
Tardio JasonChief Operating OfficerApr 8, 2022AWARD10,000——Form 4
LEVIN JEREMY MCEOApr 8, 2022AWARD423,244——Form 4
Rona Jeffrey ACBFOApr 8, 2022AWARD194,399$3.22$626.0KForm 4
Rona Jeffrey ACBFOApr 8, 2022AWARD194,399——Form 4
Rona Jeffrey ACBFOApr 8, 2022AWARD10,000$3.22$32.2KForm 4
Perone Thomas MichaelGeneral Counsel, SecretaryApr 8, 2022AWARD25,399$3.22$81.8KForm 4
Perone Thomas MichaelGeneral Counsel, SecretaryApr 8, 2022AWARD10,000$3.22$32.2KForm 4